03/28/2025 3:30 PM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form POS AM | |
03/20/2025 3:30 PM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/04/2025 3:30 PM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/28/2025 3:43 PM | Carter Denise P. (Filed by) Quoin Pharmaceuticals, Ltd. (Subject) Quoin Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
01/28/2025 3:44 PM | Myers Michael (Filed by) Quoin Pharmaceuticals, Ltd. (Subject) Quoin Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
01/23/2025 3:15 PM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/16/2025 3:30 PM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/06/2025 3:34 PM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/02/2025 4:20 PM | Myers Michael (Filed by) Quoin Pharmaceuticals, Ltd. (Subject) Quoin Pharmaceuticals (Subject)
| Form SCHEDULE 13D | |
01/02/2025 4:20 PM | Carter Denise P. (Filed by) Quoin Pharmaceuticals, Ltd. (Subject) Quoin Pharmaceuticals (Subject)
| Form SCHEDULE 13D | |
12/27/2024 4:15 PM | Culverwell Anthony James (Reporting) Quoin Pharmaceuticals, Ltd. (Issuer) Quoin Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for QNRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Quoin Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
12/27/2024 4:16 PM | Dunn Gordon (Reporting) Quoin Pharmaceuticals, Ltd. (Issuer) Quoin Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/27/2024 4:16 PM | Myers Michael (Reporting) Quoin Pharmaceuticals, Ltd. (Issuer) Quoin Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/27/2024 4:17 PM | Carter Denise P. (Reporting) Quoin Pharmaceuticals, Ltd. (Issuer) Quoin Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/26/2024 8:00 AM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/23/2024 8:01 AM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form 424B4 | |
12/22/2024 11:15 PM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form EFFECT | |
12/19/2024 8:00 AM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/18/2024 3:01 PM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form S-1/A | |
12/11/2024 3:20 PM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
12/11/2024 5:01 AM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form 424B3 | |
12/10/2024 3:45 PM | LANGER DENNIS (Reporting) Quoin Pharmaceuticals, Ltd. (Issuer) Quoin Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/10/2024 3:46 PM | Leong Natalie Ee Mun (Reporting) Quoin Pharmaceuticals, Ltd. (Issuer) Quoin Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/10/2024 3:47 PM | Myers Michael (Reporting) Quoin Pharmaceuticals, Ltd. (Issuer) Quoin Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/10/2024 3:47 PM | Quoin Pharmaceuticals, Ltd. (Issuer) Quoin Pharmaceuticals (Issuer) SEMBER MICHAEL T (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/10/2024 3:49 PM | Carter Denise P. (Reporting) Quoin Pharmaceuticals, Ltd. (Issuer) Quoin Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/10/2024 3:50 PM | Culverwell Anthony James (Reporting) Quoin Pharmaceuticals, Ltd. (Issuer) Quoin Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/10/2024 3:51 PM | Dunn Gordon (Reporting) Quoin Pharmaceuticals, Ltd. (Issuer) Quoin Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/10/2024 3:52 PM | Cooper Joseph Patrick (Reporting) Quoin Pharmaceuticals, Ltd. (Issuer) Quoin Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/10/2024 3:30 PM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2024 6:23 PM | Lind Global Fund II LP (Filed by) Quoin Pharmaceuticals, Ltd. (Subject) Quoin Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/08/2024 4:04 PM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form 424B3 | |
10/31/2024 3:30 PM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/24/2024 5:15 AM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form ARS | |
10/24/2024 5:15 AM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form DEF 14A | |
10/11/2024 3:56 PM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form PRE 14A | |
09/30/2024 5:07 AM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/11/2024 3:30 PM | Dunn Gordon (Reporting) Quoin Pharmaceuticals, Ltd. (Issuer) Quoin Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 11:03 AM | Myers Michael (Reporting) Quoin Pharmaceuticals, Ltd. (Issuer) Quoin Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 11:06 AM | Carter Denise P. (Reporting) Quoin Pharmaceuticals, Ltd. (Issuer) Quoin Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/12/2024 3:32 PM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form 424B3 | |
New “Trump” currency proposed in DC (Ad) According to one of the most connected men in Washington…
A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note.
All to celebrate a new “golden age” for America.
 When you see what could happen – I think you’ll be excited. |
06/07/2024 11:24 AM | LANGER DENNIS (Reporting) Quoin Pharmaceuticals, Ltd. (Subject) Quoin Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/03/2024 11:15 PM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form EFFECT | |
04/02/2024 10:04 AM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form DEFA14A | |
03/29/2024 3:11 PM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form POS AM | |